Apolipoprotein E genotype and lifetime cognitive decline

Nicholas A. Kozauer, Michelle M Mielke, Gary Kwun Chuen Chan, George W. Rebok, Constantine G. Lyketsos

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objective: The relationship of apolipoprotein E (APOE) genotype to lifetime cognitive decline was examined over 22 years in a large community-based population study. Method: The sample for the present study was derived from follow-up of a probability sample of the adult household residents of East Baltimore. From the Baltimore cohort of the Epidemiologic Catchment Area Study, genotype data were collected on 818 participants at the study's fourth wave between 2003 and 2004. Participants were administered the Mini-mental State Examination (MMSE) at all four study waves. Three tests of verbal learning - immediate recall, delayed recall, and word recognition - were completed at waves 3 and 4. The 659 participants for whom genetic data were available had also completed cognitive testing at all time points. Test scores and changes in these scores were examined by APOE genotype group (x/x or 4/x) in younger and older subcohorts defined by age at wave 4 (< or ≥ age 65). Results: Cross-sectional wave 4 scores on all four cognitive tasks were lower in APOEε4 carriers when compared to non-carriers. In longitudinal univariate models ε4 carriers in the younger cohort demonstrated a greater annual rate of decline on a delayed recall task and MMSE. After adjusting for covariates only the decline in the delayed recall task was significant. Conclusion: We report an association between APOE genotype and decline in delayed recall and possibly MMSE over this extended time period limited to younger individuals. The lack of an association between APOE and decline in older individuals is likely to be the result of survival bias. Although a clear association exists between APOE genotype and cognitive decline or dementia in late life, these findings suggest that over the lifespan the relationship between APOE and cognitive decline is more complicated.

Original languageEnglish (US)
Pages (from-to)109-123
Number of pages15
JournalInternational Psychogeriatrics
Volume20
Issue number1
DOIs
StatePublished - May 2008
Externally publishedYes

Fingerprint

Apolipoproteins E
Genotype
Baltimore
Verbal Learning
Sampling Studies
Short-Term Memory
Dementia
Cognitive Dysfunction
Population

Keywords

  • Aging
  • Alzheimer's disease
  • Cognition
  • Genetics
  • Neuropsychology

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Aging
  • Psychiatry and Mental health
  • Psychology(all)
  • Clinical Psychology

Cite this

Kozauer, N. A., Mielke, M. M., Chuen Chan, G. K., Rebok, G. W., & Lyketsos, C. G. (2008). Apolipoprotein E genotype and lifetime cognitive decline. International Psychogeriatrics, 20(1), 109-123. https://doi.org/10.1017/S104161020700587X

Apolipoprotein E genotype and lifetime cognitive decline. / Kozauer, Nicholas A.; Mielke, Michelle M; Chuen Chan, Gary Kwun; Rebok, George W.; Lyketsos, Constantine G.

In: International Psychogeriatrics, Vol. 20, No. 1, 05.2008, p. 109-123.

Research output: Contribution to journalArticle

Kozauer, NA, Mielke, MM, Chuen Chan, GK, Rebok, GW & Lyketsos, CG 2008, 'Apolipoprotein E genotype and lifetime cognitive decline', International Psychogeriatrics, vol. 20, no. 1, pp. 109-123. https://doi.org/10.1017/S104161020700587X
Kozauer, Nicholas A. ; Mielke, Michelle M ; Chuen Chan, Gary Kwun ; Rebok, George W. ; Lyketsos, Constantine G. / Apolipoprotein E genotype and lifetime cognitive decline. In: International Psychogeriatrics. 2008 ; Vol. 20, No. 1. pp. 109-123.
@article{11d0232a1dc94831be97ae484609a0e9,
title = "Apolipoprotein E genotype and lifetime cognitive decline",
abstract = "Objective: The relationship of apolipoprotein E (APOE) genotype to lifetime cognitive decline was examined over 22 years in a large community-based population study. Method: The sample for the present study was derived from follow-up of a probability sample of the adult household residents of East Baltimore. From the Baltimore cohort of the Epidemiologic Catchment Area Study, genotype data were collected on 818 participants at the study's fourth wave between 2003 and 2004. Participants were administered the Mini-mental State Examination (MMSE) at all four study waves. Three tests of verbal learning - immediate recall, delayed recall, and word recognition - were completed at waves 3 and 4. The 659 participants for whom genetic data were available had also completed cognitive testing at all time points. Test scores and changes in these scores were examined by APOE genotype group (x/x or 4/x) in younger and older subcohorts defined by age at wave 4 (< or ≥ age 65). Results: Cross-sectional wave 4 scores on all four cognitive tasks were lower in APOEε4 carriers when compared to non-carriers. In longitudinal univariate models ε4 carriers in the younger cohort demonstrated a greater annual rate of decline on a delayed recall task and MMSE. After adjusting for covariates only the decline in the delayed recall task was significant. Conclusion: We report an association between APOE genotype and decline in delayed recall and possibly MMSE over this extended time period limited to younger individuals. The lack of an association between APOE and decline in older individuals is likely to be the result of survival bias. Although a clear association exists between APOE genotype and cognitive decline or dementia in late life, these findings suggest that over the lifespan the relationship between APOE and cognitive decline is more complicated.",
keywords = "Aging, Alzheimer's disease, Cognition, Genetics, Neuropsychology",
author = "Kozauer, {Nicholas A.} and Mielke, {Michelle M} and {Chuen Chan}, {Gary Kwun} and Rebok, {George W.} and Lyketsos, {Constantine G.}",
year = "2008",
month = "5",
doi = "10.1017/S104161020700587X",
language = "English (US)",
volume = "20",
pages = "109--123",
journal = "International psychogeriatrics / IPA",
issn = "1041-6102",
publisher = "Cambridge University Press",
number = "1",

}

TY - JOUR

T1 - Apolipoprotein E genotype and lifetime cognitive decline

AU - Kozauer, Nicholas A.

AU - Mielke, Michelle M

AU - Chuen Chan, Gary Kwun

AU - Rebok, George W.

AU - Lyketsos, Constantine G.

PY - 2008/5

Y1 - 2008/5

N2 - Objective: The relationship of apolipoprotein E (APOE) genotype to lifetime cognitive decline was examined over 22 years in a large community-based population study. Method: The sample for the present study was derived from follow-up of a probability sample of the adult household residents of East Baltimore. From the Baltimore cohort of the Epidemiologic Catchment Area Study, genotype data were collected on 818 participants at the study's fourth wave between 2003 and 2004. Participants were administered the Mini-mental State Examination (MMSE) at all four study waves. Three tests of verbal learning - immediate recall, delayed recall, and word recognition - were completed at waves 3 and 4. The 659 participants for whom genetic data were available had also completed cognitive testing at all time points. Test scores and changes in these scores were examined by APOE genotype group (x/x or 4/x) in younger and older subcohorts defined by age at wave 4 (< or ≥ age 65). Results: Cross-sectional wave 4 scores on all four cognitive tasks were lower in APOEε4 carriers when compared to non-carriers. In longitudinal univariate models ε4 carriers in the younger cohort demonstrated a greater annual rate of decline on a delayed recall task and MMSE. After adjusting for covariates only the decline in the delayed recall task was significant. Conclusion: We report an association between APOE genotype and decline in delayed recall and possibly MMSE over this extended time period limited to younger individuals. The lack of an association between APOE and decline in older individuals is likely to be the result of survival bias. Although a clear association exists between APOE genotype and cognitive decline or dementia in late life, these findings suggest that over the lifespan the relationship between APOE and cognitive decline is more complicated.

AB - Objective: The relationship of apolipoprotein E (APOE) genotype to lifetime cognitive decline was examined over 22 years in a large community-based population study. Method: The sample for the present study was derived from follow-up of a probability sample of the adult household residents of East Baltimore. From the Baltimore cohort of the Epidemiologic Catchment Area Study, genotype data were collected on 818 participants at the study's fourth wave between 2003 and 2004. Participants were administered the Mini-mental State Examination (MMSE) at all four study waves. Three tests of verbal learning - immediate recall, delayed recall, and word recognition - were completed at waves 3 and 4. The 659 participants for whom genetic data were available had also completed cognitive testing at all time points. Test scores and changes in these scores were examined by APOE genotype group (x/x or 4/x) in younger and older subcohorts defined by age at wave 4 (< or ≥ age 65). Results: Cross-sectional wave 4 scores on all four cognitive tasks were lower in APOEε4 carriers when compared to non-carriers. In longitudinal univariate models ε4 carriers in the younger cohort demonstrated a greater annual rate of decline on a delayed recall task and MMSE. After adjusting for covariates only the decline in the delayed recall task was significant. Conclusion: We report an association between APOE genotype and decline in delayed recall and possibly MMSE over this extended time period limited to younger individuals. The lack of an association between APOE and decline in older individuals is likely to be the result of survival bias. Although a clear association exists between APOE genotype and cognitive decline or dementia in late life, these findings suggest that over the lifespan the relationship between APOE and cognitive decline is more complicated.

KW - Aging

KW - Alzheimer's disease

KW - Cognition

KW - Genetics

KW - Neuropsychology

UR - http://www.scopus.com/inward/record.url?scp=37149046496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37149046496&partnerID=8YFLogxK

U2 - 10.1017/S104161020700587X

DO - 10.1017/S104161020700587X

M3 - Article

C2 - 17711604

AN - SCOPUS:37149046496

VL - 20

SP - 109

EP - 123

JO - International psychogeriatrics / IPA

JF - International psychogeriatrics / IPA

SN - 1041-6102

IS - 1

ER -